Market Closed -
Nasdaq Helsinki
08:59:54 26/04/2024 pm IST
5-day change
1st Jan Change
4.11
EUR
+3.01%
-0.84%
+10.63%
Sales 2024 *
16.79M
17.95M
1.5B
Sales 2025 *
25.35M
27.11M
2.26B
Capitalization
73.06M
78.12M
6.52B
Net income 2024 *
-3M
-3.21M
-268M
Net income 2025 *
-2M
-2.14M
-178M
EV / Sales 2024 *
4.41
x
Net Debt
2024
*
965K
1.03M
86.06M
Net Debt
2025
*
4.58M
4.89M
408M
EV / Sales 2025 *
3.06
x P/E ratio 2024 *
-18.7
x
P/E ratio 2025 *
-26.5
x
Employees
114
Yield 2024 *
-
Yield 2025 *
-
Free-Float
87.37%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Optomed Oyj, 2023 Earnings Call, Feb 15, 2024
15/02
Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
15/02
CI
Optomed Oyj Provides Revenue Guidance for the Full Year 2024
15/02
CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
15/02
CI
Optomed Oyj Announces Nomination Board
10/01
CI
Transcript : Optomed Oyj, Nine Months 2023 Earnings Call, Nov 03, 2023
03/11
Optomed Oyj Provides Revenue Guidance for the Year 2023
03/11
CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
03/11
CI
Optomed to Raise EUR4 Million Via Share Issue
21/23/21
MT
Optomed plc Announces Composition of Its Nomination Board
12/23/12
CI
Optomed to Supply Large Diabetic Retinopathy Screening Solution to Spain
18/23/18
CI
Transcript : Optomed Oyj, H1 2023 Earnings Call, Aug 04, 2023
04/23/04
Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
04/23/04
CI
Optomed Appoints Juho Himberg as the New CEO, Effective October 1, 2023
03/23/03
CI
Optomed Announces CEO Transition Plan
14/23/14
CI
More news
AVIS D'ANALYSTES DU JOUR : Stellantis, Schneider, Renault, Safran, Airbus, Valeo,Gecina, FDJ...
16/02
Wall Street plane, le luxe atterrit en catastrophe
26/23/26
AVIS D'ANALYSTES DU JOUR : Kering, Axa, Eurofins, Hermès, Scor, Nexi, Fnac, Aperam, ArgenX...
26/23/26
Small Caps : les derniers choix des stars de la gestion
17/22/17
More news 1 day +3.01%
1 week -0.84%
Current month +4.05%
1 month +3.27%
3 months +6.48%
6 months +64.40%
Current year +10.63%
More quotes
Managers
Title Age Since
Chief Executive Officer
54
01/23/01
Director of Finance/CFO
40
01/19/01
Chief Tech/Sci/R&D Officer
-
-
Members of the board
Title Age Since
Chairman
66
01/06/01
Director/Board Member
72
01/19/01
Director/Board Member
68
01/19/01
More insiders
Date
Price
Change
Volume
26/24/26
4.11
+3.01%
26,049
25/24/25
3.99
-3.86%
24,867
24/24/24
4.15
-0.84%
17,422
23/24/23
4.185
0.00%
12,663
22/24/22
4.185
+0.97%
11,443
Delayed Quote
Nasdaq Helsinki, April 26, 2024 at 08:59 pm IST
More quotes
Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
More about the company
Last Close Price
4.11
EUR
Average target price
5.8
EUR
Spread / Average Target
+41.12%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1